Results 201 to 210 of about 54,904 (251)

Anti-tau VHH therapy against PHF6: a safe approach to slowing the phenotype of tau pathology. [PDF]

Alzheimers Res Ther
Caillierez R, Leboullenger C, Leclercq S, Besegher M, Bégard S, Auger F, Maurage CA, Accart B, Mortelecque J, Dupré E, Danis C, Landrieu I, Buée L, Colin M.   +13 more
europepmc   +1 more source

Unique antibodies across the animal kingdom (birds, camelids, and sharks): therapeutic potential against human respiratory viral infections. [PDF]

Front Immunol
Basabrain AA, Alandijany TA.
europepmc   +1 more source

Competition assay between VHHs.

, 2015
Lorena Garaicoechea, Andrea Aguilar, Gabriel I. Parra, Marina Bok, Stanislav V. Sosnovtsev, Gabriela Canziani, Kim Y. Green, Karin Bok, Viviana Parreño   +8 more
openalex   +2 more sources

Development of recombinant VHH nanobodies as an alternative for clearance of equine arteritis virus in carrier stallions

, 2016
Matías Adúriz, Mariano Carossino, Yun Young Go, Cécile Vincke, Udeni B. R. Balasuriya, Serge Muyldermans, Andrés Wigdorovitz, María Eugenia Barrandeguy, Viviana Parreño   +8 more
openalex   +1 more source

Species-Dependent Structural Variations in Single-Domain Antibodies. [PDF]

Antibodies (Basel)
Baselga M, Sánchez-Prieto J, Medina Pérez VM, Schuhmacher AJ.   +3 more
europepmc   +1 more source

Implementation of a Novel Nanobody Panel for the Efficient Capture of Extracellular Vesicles from Human Plasma. [PDF]

Molecules
Tursunović M, Filipović L, Mitić N, Stevanović S, Spasojević Savković M, de Marco A, Popović M.   +6 more
europepmc   +1 more source

Computational Prediction of Single-Domain Immunoglobulin Aggregation Propensities Facilitates Discovery and Humanization of Recombinant Nanobodies. [PDF]

Antibodies (Basel)
Geyer FK, Borbeck J, Palka W, Zhou X, Takimoto J, Rabinovich B, Reifenhäuser B, Friedrich K, Kolmar H.   +8 more
europepmc   +1 more source

Adverse Selection Problems Without the Spence-Mirrlees Condition [PDF]

Araújo, Aloísio Pessoa de, Moreira, Humberto Ataíde   +1 more
core  

Engineering VHH-based chimeric antigen receptor (CAR) T cell therapy for solid tumor treatment

, 2019
Yushu Joy Xie
openalex   +1 more source

Evaluation of the Ligand-Independent Activation of a VHH-Based Anti-CD19 SynNotch Receptor by Dual-Luciferase Assay. [PDF]

Anal Sci Adv
Asaadi Y, Rahbarizadeh F.
europepmc   +1 more source